Login / Signup

Serum proteomics reveals APOE dependent and independent protein signatures in Alzheimer's disease.

Valborg GudmundsdottirElisabet FrickValur EmilssonThorarinn JonmundssonAnna SteindorsdottirErik C B JohnsonRaquel PuertaEric B DammerAnantharaman ShantaramanAmanda CanoMerce BoadaSergi ValeroPablo Garcia-GonzalezElias Freyr GudmundssonAlexander GudjonssonRebecca PittsXiazi I QiuNancy FinkelJoseph LoureiroAnthony P OrthNicholas T SeyfriedAllan L LeveyAgustin RuizThor AspelundLori L JenningsLenore J LaunerVilmundur G Gudnason
Published in: Research square (2024)
The current demand for early intervention, prevention, and treatment of late onset Alzheimer's disease (LOAD) warrants deeper understanding of the underlying molecular processes which could contribute to biomarker and drug target discovery. Utilizing high-throughput proteomic measurements in serum from a prospective population-based cohort of older adults (n = 5,294), we identified 303 unique proteins associated with incident LOAD (median follow-up 12.8 years). Over 40% of these proteins were associated with LOAD independently of APOE -ε 4 carrier status. These proteins were implicated in neuronal processes and overlapped with protein signatures of LOAD in brain and cerebrospinal fluid. We found 17 proteins which LOAD-association was strongly dependent on APOE -ε 4 carrier status. Most of them showed consistent associations with LOAD in cerebrospinal fluid and a third had brain-specific gene expression. Remarkably, four proteins in this group (TBCA, ARL2, S100A13 and IRF6) were downregulated by APOE -ε 4 yet upregulated as a consequence of LOAD as determined in a bi-directional Mendelian randomization analysis, reflecting a potential response to the disease onset. Accordingly, the direct association of these proteins to LOAD was reversed upon APOE -ε 4 genotype adjustment, a finding which we replicate in an external cohort (n = 719). Our findings provide an insight into the dysregulated pathways that may lead to the development and early detection of LOAD, including those both independent and dependent on APOE -ε 4 . Importantly, many of the LOAD-associated proteins we find in the circulation have been found to be expressed - and have a direct link with AD - in brain tissue. Thus, the proteins identified here, and their upstream modulating pathways, provide a new source of circulating biomarker and therapeutic target candidates for LOAD.
Keyphrases